Vaxcyte (PCVX) News Today

Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 59,400 shares of the company's stock, valued at approxim

US Bancorp DE decreased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 54.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,495 shares of the company's stock after selling 9,0

Vaxcyte (NASDAQ:PCVX) Hits New 1-Year High at $86.14

Swiss National Bank lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 20.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 178,000 shares of the company's stock after purchasing an additional 30

Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) SVP Elvia Cowan sold 5,000 shares of the business's stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $85.00, for a total value of $425,000.00. Following the completion of the sale, the senior vice president now owns 12,723 shares of the company's stock, valued at $1,081,455. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Mirae Asset Global Investments Co. Ltd. lessened its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 25.0% in the first quarter, according to its most recent filing with the SEC. The firm owned 38,373 shares of the company's stock after selling 12,763 shares during the quarter. M

Vaxcyte (NASDAQ:PCVX) Reaches New 1-Year High at $82.80

Jennison Associates LLC lowered its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 14.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,256,883 shares of the company's stock after selling 219,271 shares during the quar

Capstone Investment Advisors LLC purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 109,389 shares of the company's stock, valued at approximately $7,472,000. Capstone Inv

Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the business's stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $76.37, for a total value of $127,308.79. Following the transaction, the senior vice president now owns 30,826 shares of the company's stock, valued at $2,354,181.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Allspring Global Investments Holdings LLC lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 109.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,388 shares of the company's stock after buying an additional 24,785 share

Vaxcyte (NASDAQ:PCVX) Shares Down 3.8%

Needham & Company LLC reiterated a "buy" rating and issued a $95.00 target price on shares of Vaxcyte in a report on Friday.

Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CEO Grant Pickering sold 15,000 shares of the company's stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $75.64, for a total value of $1,134,600.00. Following the completion of the transaction, the chief executive officer now directly owns 478,888 shares in the company, valued at $36,223,088.32. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Vanguard Group Inc. raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,452,371 shares of the company's stock after buying an additional 168,125 shares duri

Goldman Sachs Group Inc. grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 481,119 shares of the company's stock after buying an additiona

Cantor Fitzgerald reissued an "overweight" rating on shares of Vaxcyte in a report on Thursday.

Wellington Management Group LLP trimmed its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 3.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,431,920 shares of the company's stock after selling

Perceptive Advisors LLC trimmed its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 18.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,088,486 shares of the company's stock after selling 254,265 s

Parkman Healthcare Partners LLC increased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 267,594 shares of the company's stock afte

Braidwell LP cut its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 20.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,289,965 shares of the company's stock after sell

Kynam Capital Management LP decreased its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 23.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,002,407 shares of the company's stock after selling 300,000 shares during the period. Vaxcyte compri

Vestal Point Capital LP purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 525,000 shares of the company's stock, valued at approximately $3

Sectoral Asset Management Inc. cut its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 93.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,050 shares of the company's stock after selling 113,180 shares during the period. Secto

Capital Research Global Investors boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,440,107 shares of the company's stock after acquiring an

Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the firm's stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $120,124.02. Following the sale, the senior vice president now directly owns 31,161 shares in the company, valued at approximately $2,245,461.66. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

TD Asset Management Inc grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 10.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,036 shares of the company's stock after buying an addi

UBS Group AG lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 123.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 166,034 shares of the company's stock after acquiring an additional 91,

Monashee Investment Management LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 37,500 shares of the company's stock,

Norges Bank purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 915,512 shares of the company's stock, valued at approximately $57,494

Westfield Capital Management Co. LP grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 45.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,455,593 shares of the company's stock after buying

Franklin Resources Inc. lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,076,920 shares of the company's stock after purchasing

Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the firm's stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $74.99, for a total transaction of $599,920.00. Following the transaction, the chief financial officer now directly owns 95,679 shares in the company, valued at approximately $7,174,968.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Charles Schwab Investment Management Inc. grew its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 730,438 shares of the com

Natixis Advisors L.P. purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 14,035 shares of the company's stock, valued at approximately $88